Results 1 to 10 of about 48,929 (237)
Management of in-stent restenosis
EuroIntervention, 2022 In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI procedures performed in current clinical practice. This State-of-the-Art review will primarily focus on the management of ISR but will begin by briefly discussing ...
Alfonso, Fernando +4 more
openaire +5 more sources
JACC: Basic to Translational Science, 2020 Anna Lena Lahmann, MD, Michael Joner, MD
doaj +4 more sources
Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review [PDF]
Zhongguo quanke yixue, 2023 As a major treatment for coronary artery disease, percutaneous coronary intervention (PCI) effectively enhances the survival rate of patients. However, the post-PCI in-stent restenosis has become a new cardiovascular problem that is difficult to solve ...
AN Jingjing, WANG Xiaojuan, DENG Aiyun
doaj +1 more source
A computational model of coronary arteries with in-stent restenosis coupling hemodynamics and pharmacokinetics with growth mechanics [PDF]
Scientific ReportsDespite advances in stent technology, in-stent restenosis remains a critical challenge following percutaneous coronary intervention. In this work, we propose a comprehensive fluid-solid computational model to simulate restenosis after drug-eluting stent ...
Anna Ranno +13 more
doaj +2 more sources
Cardiovascular Therapeutics, 2011 The introduction of coronary stents marked a major turning point in the practice of interventional cardiology. Whereas the efficacy of balloon angioplasty was challenged both by immediate mechanical complications and by a high incidence of restenosis, coronary stents offered cardiologists a means by which to not only augment immediate procedural ...
Michael S Kim, Larry S Dean
exaly +2 more sources
Interventional Cardiology Clinics, 2016 In-stent restenosis (ISR) is the narrowing of a stented coronary artery lesion. The mean time from percutaneous coronary intervention (PCI) to ISR was 12 months with drug-eluting stents (DES) and 6 months with bare metal stents (BMS). ISR typically presents as recurrent angina. The use of DES has significantly reduced the rate of ISR compared with BMS.
Michael S, Lee, Gaurav, Banka
+6 more sources
Frontiers in Cardiovascular Medicine, 2022 PurposeAs a second-generation drug-eluting stent, the restenosis risk factors of the everolimus-eluting stent (EES) lack sufficient evidence. Therefore, the study investigated the in-stent restenosis occurrence and its predictive factors among patients ...
Qiang Feng +5 more
doaj +1 more source
Pathogenetic mechanisms of repeated adverse cardiovascular events development in patients with coronary heart disease: the role of chronic inflammation [PDF]
Folia Medica, 2023 Stent restenosis is the most unfavorable complication of interventional treatment for coronary heart disease. We already know from various literature sources that the causes for stent restenosis in patients are both mechanical damage (partial opening ...
Irina Starodubtseva +2 more
doaj +3 more sources
Dealing with in-stent restenosis [PDF]
Heart, 1998 Stents have been shown to reduce the incidence of restenosis; however, they are not a cure. In two trials the angiographic restenosis rate was reported to be between 20% and 30% (in the Benestent II trial the unpublished quoted restenosis rate was 15%). These trials were based on stenting short, de novo lesions, in native coronary arteries.
A H, Gershlick, J, Baron
openaire +2 more sources
BMC Neurology, 2023 Background Prognosis after vertebrobasilar stenting (VBS) may differ from that after carotid artery stenting (CAS). Here, we directly compared the incidence and predictors of in-stent restenosis and stented-territory infarction after VBS and compared ...
Jae-Chan Ryu +10 more
doaj +1 more source